Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 11;14(1):153.
doi: 10.1186/s13048-021-00911-z.

Investigation on factors associated with ovarian cancer: an umbrella review of systematic review and meta-analyses

Kiarash Tanha #  1 , Azadeh Mottaghi #  2 , Marzieh Nojomi  3   4 , Marzieh Moradi  5 , Rezvan Rajabzadeh  6 , Samaneh Lotfi  5 , Leila Janani  7
Affiliations

Investigation on factors associated with ovarian cancer: an umbrella review of systematic review and meta-analyses

Kiarash Tanha et al. J Ovarian Res. .

Abstract

Following cervical and uterine cancer, ovarian cancer (OC) has the third rank in gynecologic cancers. It often remains non-diagnosed until it spreads throughout the pelvis and abdomen. Identification of the most effective risk factors can help take prevention measures concerning OC. Therefore, the presented review aims to summarize the available studies on OC risk factors. A comprehensive systematic literature search was performed to identify all published systematic reviews and meta-analysis on associated factors with ovarian cancer. Web of Science, Cochrane Library databases, and Google Scholar were searched up to 17th January 2020. This study was performed according to Smith et al. methodology for conducting a systematic review of systematic reviews. Twenty-eight thousand sixty-two papers were initially retrieved from the electronic databases, among which 20,104 studies were screened. Two hundred seventy-seven articles met our inclusion criteria, 226 of which included in the meta-analysis. Most commonly reported genetic factors were MTHFR C677T (OR=1.077; 95 % CI (1.032, 1.124); P-value<0.001), BSML rs1544410 (OR=1.078; 95 %CI (1.024, 1.153); P-value=0.004), and Fokl rs2228570 (OR=1.123; 95 % CI (1.089, 1.157); P-value<0.001), which were significantly associated with increasing risk of ovarian cancer. Among the other factors, coffee intake (OR=1.106; 95 % CI (1.009, 1.211); P-value=0.030), hormone therapy (RR=1.057; 95 % CI (1.030, 1.400); P-value<0.001), hysterectomy (OR=0.863; 95 % CI (0.745, 0.999); P-value=0.049), and breast feeding (OR=0.719, 95 % CI (0.679, 0.762) and P-value<0.001) were mostly reported in studies. Among nutritional factors, coffee, egg, and fat intake significantly increase the risk of ovarian cancer. Estrogen, estrogen-progesterone, and overall hormone therapies also are related to the higher incidence of ovarian cancer. Some diseases, such as diabetes, endometriosis, and polycystic ovarian syndrome, as well as several genetic polymorphisms, cause a significant increase in ovarian cancer occurrence. Moreover, other factors, for instance, obesity, overweight, smoking, and perineal talc use, significantly increase the risk of ovarian cancer.

Keywords: Environmental factors; Genetic factors; Nutritional factors; Ovarian cancer; Protective factor; Risk factor.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest associated with the publication of this manuscript to declare. The authors report no financial disclosures related to the current work.

Figures

Fig. 1
Fig. 1
SIGN Checklist scoring
Fig. 2
Fig. 2
PRISMA flow diagram
Fig. 3
Fig. 3
Meta-analysis of OR for MTHFR C677T, BSML rs1544410 and Fokl rs2228570
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Skates SJ, Greene MH, Buys SS, Mai PL, Brown P, Piedmonte M, et al. Early detection of ovarian cancer using the risk of ovarian cancer algorithm with frequent CA125 testing in women at increased familial risk–combined results from two screening trials. Clin Cancer Res. 2017;23(14):3628–37. doi: 10.1158/1078-0432.CCR-15-2750. - DOI - PMC - PubMed
    1. Society AC. Survival Rates for Ovarian Cancer 2021 [cited 2021 September 13, 2021]. Available from: https://www.cancer.org/cancer/ovarian-cancer/detection-diagnosis-staging....
    1. Jacobs IJ, Menon U. Progress and challenges in screening for early detection of ovarian cancer. Mol Cell Proteomics. 2004;3(4):355–66. doi: 10.1074/mcp.R400006-MCP200. - DOI - PubMed
    1. Elias KM, Guo J, Bast RC. Early detection of ovarian cancer. Hematol Oncol Clin. 2018;32(6):903–14. doi: 10.1016/j.hoc.2018.07.003. - DOI - PMC - PubMed
    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2018;68(6):394–424. doi: 10.3322/caac.21492. - DOI - PubMed

Publication types